Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Langer

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 29, 2013
Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?Joshua Bauml, Rosemarie Mick, Yu Zhang, et al.
Clinical Lung Cancer|June 16, 2018
Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/CarboplatinVera Hirsh, Yin Wan, Fang-Ju Lin, et al.
Journal of Palliative Medicine|June 27, 2012
Utilization of supportive and palliative care services among oncology outpatients at one academic cancer center: determinants of use and barriers to accessPallavi Kumar, David Casarett, Amy Corcoran, et al.
Oncology|February 17, 2005
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancerThomas Delea, Corey Langer, James McKiernan, et al.
Clinical Lung Cancer|December 16, 2011
International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom controlGeorge Rodrigues, Fergus Macbeth, Bryan Burmeister, et al.
The New England Journal of Medicine|January 11, 2002
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancerJoan H Schiller, David Harrington, Chandra P Belani, et al.
Current Problems in Diagnostic Radiology|March 26, 2018
Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 TherapyMark Hammer, Stephen Bagley, Charu Aggarwal, et al.
Cancer Medicine|April 16, 2023
Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer DatabasePatrick Bou-Samra, Austin Chang, Feredun Azari, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapyAnnemarie T Fernandes, Nandita Mitra, Eric Xanthopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort studyCorey Langer, Arliene Ravelo, Sebastien J Hazard, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Lung Cancer (Amsterdam, Netherlands)|June 29, 2013
Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?Joshua Bauml, Rosemarie Mick, Yu Zhang, et al.
Clinical Lung Cancer|June 16, 2018
Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/CarboplatinVera Hirsh, Yin Wan, Fang-Ju Lin, et al.
Journal of Palliative Medicine|June 27, 2012
Utilization of supportive and palliative care services among oncology outpatients at one academic cancer center: determinants of use and barriers to accessPallavi Kumar, David Casarett, Amy Corcoran, et al.
Oncology|February 17, 2005
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancerThomas Delea, Corey Langer, James McKiernan, et al.
Clinical Lung Cancer|December 16, 2011
International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom controlGeorge Rodrigues, Fergus Macbeth, Bryan Burmeister, et al.
The New England Journal of Medicine|January 11, 2002
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancerJoan H Schiller, David Harrington, Chandra P Belani, et al.
Current Problems in Diagnostic Radiology|March 26, 2018
Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 TherapyMark Hammer, Stephen Bagley, Charu Aggarwal, et al.
Cancer Medicine|April 16, 2023
Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer DatabasePatrick Bou-Samra, Austin Chang, Feredun Azari, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapyAnnemarie T Fernandes, Nandita Mitra, Eric Xanthopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort studyCorey Langer, Arliene Ravelo, Sebastien J Hazard, et al.
Pageof 11